Federation des caisses Desjardins du Quebec’s BeOne Medicines Ltd ONC Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$428K	Buy	1,503 +1,366	+997%	+$403K	﹤0.01%	1414
2026 Q1	$40.7K	Buy	137 +135	+6,750%	+$43.7K	﹤0.01%	1921
2025 Q4	$608	Buy	+2	New	+$655	﹤0.01%	2719
2025 Q3	–	Sell	-5	Closed	-$1.21K	–	3006
2025 Q2	$1.21K	Hold	5	–	–	﹤0.01%	2480
2025 Q1	$1.36K	Hold	5	–	–	﹤0.01%	2386
2024 Q4	$924	Hold	5	–	–	﹤0.01%	2329
2024 Q3	$1.12K	Buy	+5	New	+$900	﹤0.01%	2305
2024 Q2	–	Sell	-10	Closed	-$1.56K	–	2586
2024 Q1	$1.56K	Buy	10 +1	+11%	+$161	﹤0.01%	2144
2023 Q4	$1.62K	Buy	9 +4	+80%	+$724	﹤0.01%	2093
2023 Q3	$899	Buy	+5	New	+$989	﹤0.01%	2158
2021 Q2	–	Sell	-17	Closed	-$5.9K	–	2588
2021 Q1	$5.9K	Sell	17 -2,242	-99%	-$742K	﹤0.01%	2155
2020 Q4	$584K	Sell	2,259 -1,247	-36%	-$343K	0.01%	748
2020 Q3	$1M	Buy	+3,506	New	+$824K	0.01%	559
2018 Q4	–	Sell	-28	Closed	-$4.82K	–	2156
2018 Q3	$4.82K	Buy	+28	New	+$4.71K	﹤0.01%	1886
2018 Q2	–	Sell	-277	Closed	-$46.5K	–	2246
2018 Q1	$46.5K	Buy	+277	New	+$37.5K	﹤0.01%	1351

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's ONC Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its BeOne Medicines Ltd (ONC) stake by 997% in Q2 2026, buying an estimated $403K and bringing the position to 1,503 shares worth $428K. The position accounts for ﹤0.01% of the portfolio, ranked #1414.

Federation des caisses Desjardins du Quebec first reported a position in ONC in Q1 2018 and has held it in 15 quarters since. The position peaked at $1M in Q3 2020. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Federation des caisses Desjardins du Quebec held 1,503 shares of BeOne Medicines Ltd worth $428K as of Q2 2026.
Federation des caisses Desjardins du Quebec bought 1,366 BeOne Medicines Ltd shares in Q2 2026, an estimated $403K.
BeOne Medicines Ltd made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #1414 holding.
Federation des caisses Desjardins du Quebec first reported a position in BeOne Medicines Ltd in Q1 2018 and has held it in 15 quarters since.
Federation des caisses Desjardins du Quebec's BeOne Medicines Ltd position peaked at $1M in Q3 2020.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.